Jiangsu Cancer Institute & Hospital

This study is testing whether adding a newer targeted drug called disitamab vedotin to standard chemotherapy and bevacizumab works better for certain high-risk ovarian cancers. It will involve 43 patients whose cancer has specific features (HER2-positive and HRD-negative) and is …

This study is testing whether a chemotherapy pill (oral paclitaxel) combined with radiation is safe and effective for patients with advanced esophageal cancer that cannot be surgically removed. It focuses on older patients or those too frail for standard intravenous chemotherapy,…

This study is testing whether adding two new immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemotherapy works better for people with stage III non-small cell lung cancer that cannot be removed by surgery. The trial will enroll 33 patients who haven't had previous…